[Ecstasy: from recreational drug to toxic substance].
Franck
N
N
Service de Psychiatrie et de Psychologie médicale, Université de Liège.
Bertrand
J
J
D000293:Adolescent; D018759:Adrenergic Uptake Inhibitors / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000494:pharmacology / Q000506:poisoning; D000328:Adult; D000662:Amphetamines / Q000494:pharmacology; D000818:Animals; D001669:Biochemical Phenomena; D001671:Biochemistry; D000697:Central Nervous System Stimulants / Q000494:pharmacology; D003710:Demography; D015198:Designer Drugs / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000494:pharmacology / Q000506:poisoning; D006213:Hallucinogens / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000494:pharmacology / Q000506:poisoning; D006801:Humans; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000494:pharmacology / Q000506:poisoning; D019965:Neurocognitive Disorders / Q000139:chemically induced; D009474:Neurons / Q000187:drug effects
D018759:Adrenergic Uptake Inhibitors; D000662:Amphetamines; D000697:Central Nervous System Stimulants; D015198:Designer Drugs; D006213:Hallucinogens; D018817:N-Methyl-3,4-methylenedioxyamphetamine
L'ecstasy: de la drogue récréative à la substance toxique.